{"id":117561,"date":"2023-05-09T15:28:49","date_gmt":"2023-05-09T19:28:49","guid":{"rendered":"https:\/\/v2fr5er78d.funnewsdaily.com\/books\/epilepsy-drugs-market-is-expected-to-reach-9-8-billion-by-2032-allied-market-research\/"},"modified":"2023-05-09T15:28:49","modified_gmt":"2023-05-09T19:28:49","slug":"epilepsy-drugs-market-is-expected-to-reach-9-8-billion-by-2032-allied-market-research","status":"publish","type":"post","link":"https:\/\/v2fr5er78d.funnewsdaily.com\/books\/epilepsy-drugs-market-is-expected-to-reach-9-8-billion-by-2032-allied-market-research\/","title":{"rendered":"Epilepsy Drugs Market Is Expected to Reach $9.8 Billion by 2032: Allied Market Research"},"content":{"rendered":"
<\/p>\n
\/EIN News<\/a>\/ — Portland, OR, May 05, 2023 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global epilepsy drugs market<\/u><\/a> generated $7 billion in 2022, and is estimated to reach $9.8 billion by 2032, witnessing a CAGR of 3.5% from 2023 to 2032.<\/b> The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.<\/p>\n Request Sample Report- https:\/\/www.alliedmarketresearch.com\/request-sample\/1497<\/u><\/a> <\/b><\/p>\n Report coverage & details:<\/b><\/p>\n